Endologix INC /DE/
SEC CIK 1013606 · ELGX · last insider filing 2020-09-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lemaitre Dan | Director | filed 2009 - 2020 |
| Waller Gregory D | Director | filed 2006 - 2020 |
| Onopchenko John | Director · Chief Operating Officer | filed 2017 - 2020 |
| Wilder Thomas | Director | filed 2010 - 2020 |
| Mott Richard W | Director | filed 2020 - 2020 |
| Kiernan Jane E | Director | filed 2020 - 2020 |
| Zenty III Thomas F | Director | filed 2013 - 2019 |
| Norwalk Leslie V | Director | filed 2015 - 2019 |
| Neels Guido J | Director | filed 2010 - 2019 |
| Chavez Christopher G. | Director | filed 2016 - 2018 |
| Mcdermott John D | Director · Chief Executive Officer | filed 2008 - 2018 |
| DE Greef Roderick | Director | filed 2006 - 2013 |
| Brown Franklin D | Director | filed 2006 - 2011 |
| Odonnell Jeffrey F | Director | filed 2006 - 2010 |
| Mccormick Paul | Director · Chief Executive Officer & Pres | filed 2006 - 2010 |
| Diethrich Edward | Director | filed 2006 - 2008 |
| Coelyn Ronald H | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Thompson Matthew | Chief Medical Officer | filed 2018 - 2020 |
| Brady Timothy Nicholas | Controller and Corp Secretary | filed 2020 - 2020 |
| Pinto Cynthia Buch | Interim CFO | filed 2020 - 2020 |
| Fecho Jeff | Chief Quality Officer | filed 2019 - 2020 |
| Mahboob Vaseem | VP, Quality | filed 2015 - 2020 |
| Zehren John | Chief Commercial Officer | filed 2019 - 2020 |
| Hayden Jeremy B. | General Counsel | filed 2018 - 2019 |
| Nagel Laura | VP, Quality | filed 2017 - 2018 |
| Mitchell Robert D | President, International | filed 2010 - 2017 |
| O'Quinn Shari L | VP, Clinical & Regulatory | filed 2016 - 2017 |
| Chobotov Michael V. | Chief Technology Officer | filed 2016 - 2016 |
| Lima Jose A. | VP-Quality | filed 2014 - 2016 |
| Dejohn Joseph A. | Vice President - Sales | filed 2008 - 2016 |
| Jennings David M. | VP-Human Resources | filed 2013 - 2016 |
| Machek James Edward | VP-Research & Development | filed 2013 - 2016 |
| Depalma Amanda L. | VP, Global Marketing | filed 2014 - 2016 |
| Ferracci Cecile | General Manager, Europe | filed 2015 - 2016 |
| Love Charles Steele | VP-Clinical Affairs | filed 2012 - 2016 |
| Abraham Todd | VP of Operations | filed 2010 - 2015 |
| Thunen Shelley B | Chief Financial Officer | filed 2013 - 2015 |
| Fauls Janet Mary | Vice President RA/QA/QC | filed 2007 - 2015 |
| Lyons Ruth Anne | VP Global Marketing | filed 2011 - 2014 |
| Schreck Stefan | Vice President | filed 2006 - 2013 |
| Greenstein Leonard M. | VP Finance & Corp Controller | filed 2011 - 2013 |
| Sorsher Gary I. | Vice President - Quality | filed 2008 - 2013 |
| Tyler Martin | VP, International | filed 2010 - 2013 |
| Krist Robert John | Chief Financial Officer | filed 2006 - 2012 |
| Hawkins Daniel | Vice Pres - Global Marketing | filed 2009 - 2009 |
| Uyesugi Karen | Vice President | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.